A recent study from the University of Bristol offers new hope for people with diabetes, who are at a high risk of kidney ...

Diabetes doesn’t just impact blood sugar; it often leads to serious kidney issues, too. In fact, about 40% of people with diabetes develop a condition known as diabetic kidney disease. In the UK, ...

Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced that it has been awarded a $2.2 million contract from the Joint Warfighter ...

MIIST305, derived from this platform, is a non-systemic therapeutic that modulates innate immune receptor responses and targets the anionic glycocalyx at the gastrointestinal cell surface to ...

MIIST305, derived from this platform, is a non-systemic therapeutic that modulates innate immune receptor responses and targets the anionic glycocalyx at the gastrointestinal cell surface to repair ...